The CDC’s ACIP updated guidance on pneumococcal vaccination, recommending a single dose of PCV for all adults aged 50 years and older.

Twelve months after revaccination, antibody levels declined but remained significantly higher than baseline in patients with CLL.

Just a month after getting approval for its new pneumococcal vaccine Vaxneuvance in adults, Merck & Co has reported positive trial results in children that will ramp up the pressure on Pfizer and ...

Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal vaccines, taking a 21-valent shot licensed from SK Biosciences into phase 3 testing.

Share on Pinterest After a two-month delay, a CDC panel met last week to discuss vaccine guidelines for COVID-19, RSV, HPV, and other infectious diseases. Luis Alvarez/Getty Images The CDC is ...

Next year’s COVID vaccine recommendations from the U.S. Centers for Disease Control and Prevention appear likely to be less expansive than in previous years. Notes from a recent meeting of the ...

The panel is expected to vote on the COVID-19 and other vaccination recommendations in June. In the past, CDC officials have usually implemented the suggestions made by the panel of experts.

we have been advocating for risk-based COVID-19 vaccine recommendations for years. At the recent meeting, the COVID-19 ACIP work group, made up of ACIP members, government health agency officials ...

Health and Human Services Secretary Robert F. Kennedy Jr. is considering pulling COVID-19 from the government’s vaccine recommendations for children, according to a Tuesday report from Politico.

"Though there was concern that risk-based recommendations would decrease vaccination, others pointed out there's no proof that's true."There's not clear evidence at all that risk-based approaches ...